Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › BURLESON › TEXAS HEALTH HUGULEY, INC.

TEXAS HEALTH HUGULEY, INC.

NPI: 1033120423 · BURLESON, TX 76028 · Ambulatory Surgical Clinic/Center · NPI assigned 08/10/2006

$8.51M
Total Medicaid Paid
157,632
Total Claims
144,088
Beneficiaries
117
Codes Billed
2020-07
First Month
2024-12
Last Month

Provider Details

Authorized OfficialJOHNSON, PENNY (CHIEF EXECUTIVE OFFICER)
NPI Enumeration Date08/10/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 4,157 $229K
2021 37,788 $1.44M
2022 46,559 $2.02M
2023 45,778 $3.38M
2024 23,350 $1.44M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 10,362 9,616 $2.06M
42820 Tonsillectomy and adenoidectomy; younger than age 12 421 412 $1.41M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1,344 913 $844K
99283 Emergency department visit for the evaluation and management, moderate severity 13,463 12,819 $702K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 4,283 4,085 $471K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 477 448 $371K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1,832 1,765 $297K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1,428 1,366 $230K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,828 1,629 $209K
42830 138 137 $191K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,217 1,177 $151K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4,000 3,808 $136K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,998 3,807 $136K
80053 Comprehensive metabolic panel 11,071 10,105 $125K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,075 976 $121K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14,521 13,031 $100K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 143 135 $71K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2,600 2,273 $70K
86780 3,762 3,529 $58K
86850 2,182 2,033 $56K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,046 1,930 $56K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 833 773 $41K
87086 Culture, bacterial; quantitative colony count, urine 4,933 4,584 $38K
84443 Thyroid stimulating hormone (TSH) 2,861 2,742 $33K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 994 949 $30K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 936 887 $28K
86762 1,620 1,540 $28K
42821 12 12 $27K
70450 Computed tomography, head or brain; without contrast material 525 492 $25K
81001 6,610 6,158 $23K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 910 877 $22K
87340 1,690 1,602 $20K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 177 122 $20K
85027 2,546 2,407 $19K
71045 Radiologic examination, chest; single view 1,448 1,269 $19K
83036 Hemoglobin; glycosylated (A1C) 2,425 2,334 $18K
80050 General health panel 84 75 $16K
71046 Radiologic examination, chest; 2 views 455 433 $13K
87081 1,684 1,656 $13K
86803 719 667 $12K
82950 1,844 1,767 $11K
84702 842 723 $10K
74176 Computed tomography, abdomen and pelvis; without contrast material 169 162 $10K
84484 1,853 1,036 $9K
81513 68 66 $9K
81025 1,171 1,090 $9K
86900 2,288 2,141 $8K
90715 374 355 $8K
86901 2,290 2,141 $8K
59025 Fetal non-stress test 201 178 $8K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 241 228 $6K
80061 Lipid panel 1,209 1,182 $6K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1,128 1,016 $5K
86003 98 32 $5K
84703 833 792 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 355 339 $5K
83880 363 330 $5K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 324 318 $4K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 62 61 $4K
74177 Computed tomography, abdomen and pelvis; with contrast material 26 26 $3K
83690 1,137 1,055 $3K
76819 Fetal biophysical profile; without non-stress testing 27 14 $3K
96375 Therapeutic injection; each additional sequential IV push 654 534 $3K
87480 170 161 $2K
87660 170 161 $2K
82077 239 221 $2K
84030 415 413 $2K
83735 580 524 $2K
80048 Basic metabolic panel (calcium, ionized) 919 788 $2K
87070 385 383 $2K
87077 559 473 $2K
82947 701 369 $2K
81511 312 293 $2K
96361 Intravenous infusion, hydration; each additional hour 112 98 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 273 250 $2K
81329 17 12 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,163 1,031 $1K
87510 102 95 $1K
85610 743 678 $1K
87481 62 61 $974.52
85730 387 361 $918.18
82247 121 81 $874.55
J7030 Infusion, normal saline solution , 1000 cc 545 482 $863.25
87040 268 148 $825.48
J2270 Injection, morphine sulfate, up to 10 mg 588 460 $810.66
86787 63 57 $763.56
87186 304 265 $722.85
99282 Emergency department visit for the evaluation and management, low to moderate severity 24 24 $719.04
81003 550 525 $708.29
J0696 Injection, ceftriaxone sodium, per 250 mg 308 278 $705.25
83605 219 176 $688.77
83021 34 29 $616.39
82248 114 112 $557.47
88305 Level IV - Surgical pathology, gross and microscopic examination 64 49 $521.18
82607 63 61 $459.52
J1885 Injection, ketorolac tromethamine, per 15 mg 383 361 $452.53
82105 34 32 $418.39
J7050 Infusion, normal saline solution, 250 cc 131 104 $325.42
82746 29 28 $269.23
82570 126 125 $261.87
82043 63 63 $144.99
82951 14 13 $118.99
86140 76 72 $99.15
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 47 43 $92.93
J1100 Injection, dexamethasone sodium phosphate, 1 mg 44 41 $87.94
84146 43 43 $87.54
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 72 69 $71.14
J7120 Ringers lactate infusion, up to 1000 cc 39 39 $64.47
J3010 Injection, fentanyl citrate, 0.1 mg 118 109 $56.76
36415 Collection of venous blood by venipuncture 14,499 12,551 $47.91
84439 12 12 $36.43
82952 14 13 $36.21
87641 14 14 $29.48
85379 12 12 $14.31
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 36 28 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 26 26 $0.00
96376 16 12 $0.00